Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
George Golumbeski Insider Profile
11 Followers
George Golumbeski, Director at Enanta Pharmaceuticals, holds 8.00K shares in SAGE Therapeutics (Ticker: SAGE), holds 54.61K shares in Shattuck Labs (Ticker: STTK), holds 0.00 shares in Enanta Pharmaceuticals (Ticker: ENTA). Most recently, George Golumbeski Bought ― shares of SAGE Therapeutics on May 09, 2022 for an estimated value of 251.52K.
George Golumbeski Enanta Pharmaceuticals (ENTA)Director
Enanta Pharmaceuticals (ENTA)
Director
Ranked #32,567 out of 98,501 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+12.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that George Golumbeski holds in companies
Most Profitable Insider Trade
The most profitable trade made by George Golumbeski
George Golumbeski's Trading History
Enanta Pharmaceuticals
Mar 06, 2019
Director
Uninformative Sell
961.87K
$0.00
SAGE Therapeutics
May 09, 2022
Director
Informative Buy
251.52K
$100.56K
Corbus Pharmaceuticals
―
Director
―
―
Shattuck Labs
Apr 27, 2022
Director
Informative Buy
102.84K
$547.22K
Acceleron Pharma
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see George Golumbeski's performance on stock
You May Also Like
George Golumbeski insider profile FAQ
What is the percentage of profitable transactions made by George Golumbeski?
The percentage of profitable transactions made by George Golumbeski is 33%.
What is the average return per transaction made by George Golumbeski?
The average return per transaction made by George Golumbeski is 12.80%.
What stocks does George Golumbeski hold?
George Golumbeski holds: ENTA, SAGE, CRBP, STTK, XLRN stocks.
What was George Golumbeski’s latest transaction?
George Golumbeski latest transaction was an Informative Buy of $251.52K.
What was George Golumbeski's most profitable transaction?
George Golumbeski’s most profitable transaction was an Informative Buy of SAGE stock on May 9, 2022. The return on the trade was 84.00%.
What is George Golumbeski's role in Enanta Pharmaceuticals?
George Golumbeski's role in Enanta Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.